PT Millennium Pharmacon International Tbk (SDPC.JK)
IDR 132.0
(0.76%)
IDR 132.0
(0.76%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 44 Billion IDR | 2814.6% |
| 2022 | 1.5 Billion IDR | -16.05% |
| 2021 | 1.79 Billion IDR | -11.43% |
| 2020 | 2.03 Billion IDR | 0.0% |
| 2019 | - IDR | 0.0% |
| 2018 | - IDR | 0.0% |
| 2017 | - IDR | -100.0% |
| 2016 | 11.64 Million IDR | -96.77% |
| 2015 | 360.27 Million IDR | -47.06% |
| 2014 | 680.49 Million IDR | 0.0% |
| 2013 | - IDR | -100.0% |
| 2012 | 55.91 Million IDR | -52.14% |
| 2011 | 116.81 Million IDR | -31.95% |
| 2010 | 171.64 Million IDR | -97.49% |
| 2009 | 6.82 Billion IDR | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 41.55 Billion IDR | -2.86% |
| 2024 Q3 | 42.49 Billion IDR | 2.26% |
| 2024 Q1 | 43.35 Billion IDR | -2.78% |
| 2023 FY | 44 Billion IDR | 2814.6% |
| 2023 Q3 | 885.74 Million IDR | -20.71% |
| 2023 Q1 | 1.54 Billion IDR | 2.26% |
| 2023 Q4 | 44 Billion IDR | 4867.57% |
| 2023 Q2 | 1.11 Billion IDR | -27.64% |
| 2022 Q2 | 1.89 Billion IDR | 2.6% |
| 2022 Q3 | 1.47 Billion IDR | -22.29% |
| 2022 FY | 1.5 Billion IDR | -16.05% |
| 2022 Q4 | 1.5 Billion IDR | 2.61% |
| 2022 Q1 | 1.84 Billion IDR | 2.61% |
| 2021 Q2 | 2.13 Billion IDR | 2.51% |
| 2021 Q1 | 2.08 Billion IDR | 2.52% |
| 2021 FY | 1.79 Billion IDR | -11.43% |
| 2021 Q4 | 1.79 Billion IDR | -16.29% |
| 2021 Q3 | 2.14 Billion IDR | 0.68% |
| 2020 FY | 2.03 Billion IDR | 0.0% |
| 2020 Q2 | - IDR | 0.0% |
| 2020 Q4 | 2.03 Billion IDR | 0.0% |
| 2020 Q1 | - IDR | 0.0% |
| 2020 Q3 | - IDR | 0.0% |
| 2019 Q2 | - IDR | 0.0% |
| 2019 FY | - IDR | 0.0% |
| 2019 Q4 | - IDR | 0.0% |
| 2019 Q1 | - IDR | 0.0% |
| 2019 Q3 | - IDR | 0.0% |
| 2018 Q2 | - IDR | 0.0% |
| 2018 FY | - IDR | 0.0% |
| 2018 Q4 | - IDR | 0.0% |
| 2018 Q3 | - IDR | 0.0% |
| 2018 Q1 | - IDR | 0.0% |
| 2017 Q2 | - IDR | 0.0% |
| 2017 Q4 | - IDR | 0.0% |
| 2017 Q3 | - IDR | 0.0% |
| 2017 FY | - IDR | -100.0% |
| 2017 Q1 | - IDR | -100.0% |
| 2016 Q1 | 268.49 Million IDR | -25.47% |
| 2016 FY | 11.64 Million IDR | -96.77% |
| 2016 Q2 | 176.2 Million IDR | -34.37% |
| 2016 Q3 | 81.38 Million IDR | -53.81% |
| 2016 Q4 | 11.64 Million IDR | -85.69% |
| 2015 Q3 | 454.52 Million IDR | -14.33% |
| 2015 Q1 | 634.81 Million IDR | -6.71% |
| 2015 FY | 360.27 Million IDR | -47.06% |
| 2015 Q4 | 360.27 Million IDR | -20.74% |
| 2015 Q2 | 530.53 Million IDR | -16.43% |
| 2014 Q3 | - IDR | 0.0% |
| 2014 FY | 680.49 Million IDR | 0.0% |
| 2014 Q4 | 680.49 Million IDR | 0.0% |
| 2014 Q1 | - IDR | 0.0% |
| 2014 Q2 | - IDR | 0.0% |
| 2013 Q4 | - IDR | -100.0% |
| 2013 Q1 | 39.66 Million IDR | 0.0% |
| 2013 Q3 | 5.85 Million IDR | -74.51% |
| 2013 Q2 | 22.98 Million IDR | -42.05% |
| 2013 FY | - IDR | -100.0% |
| 2012 Q4 | - IDR | 0.0% |
| 2012 Q3 | - IDR | 0.0% |
| 2012 FY | 55.91 Million IDR | -52.14% |
| 2011 FY | 116.81 Million IDR | -31.95% |
| 2010 FY | 171.64 Million IDR | -97.49% |
| 2009 FY | 6.82 Billion IDR | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| PT Enseval Putera Megatrading Tbk. | 2.36 Billion IDR | -1760.257% |
| PT Itama Ranoraya Tbk | 502.93 Million IDR | -8648.561% |
| PT Kimia Farma (Persero) Tbk | 972.97 Billion IDR | 95.478% |
| PT Soho Global Health Tbk | 9.44 Billion IDR | -366.102% |